314 related articles for article (PubMed ID: 19131360)
1. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
Li D; Long C; Yue Y; Duan D
Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
[TBL] [Abstract][Full Text] [Related]
2. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
[TBL] [Abstract][Full Text] [Related]
3. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice.
Yue Y; Liu M; Duan D
Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
6. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
Gawlik KI; Holmberg J; Durbeej M
Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
[TBL] [Abstract][Full Text] [Related]
7. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
8. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM
J Cell Sci; 2000 Jul; 113 ( Pt 14)():2535-44. PubMed ID: 10862711
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in dystrophin-glycoprotein complex and in utrophin are not correlated with intrinsic laryngeal muscles protection in mdx mice.
Ferretti R; Pertille A; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Dec; 44(6):978-80. PubMed ID: 22102469
[TBL] [Abstract][Full Text] [Related]
10. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
11. Independent variability of microtubule perturbations associated with dystrophinopathy.
Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM
Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583
[TBL] [Abstract][Full Text] [Related]
12. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
14. Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.
Judge LM; Arnett AL; Banks GB; Chamberlain JS
Hum Mol Genet; 2011 Dec; 20(24):4978-90. PubMed ID: 21949353
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
16. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.
Townsend D; Yasuda S; McNally E; Metzger JM
FASEB J; 2011 Sep; 25(9):3106-14. PubMed ID: 21665956
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
18. Muscle structure influences utrophin expression in mdx mice.
Banks GB; Combs AC; Odom GL; Bloch RJ; Chamberlain JS
PLoS Genet; 2014 Jun; 10(6):e1004431. PubMed ID: 24922526
[TBL] [Abstract][Full Text] [Related]
19. epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex.
Straub V; Ettinger AJ; Durbeej M; Venzke DP; Cutshall S; Sanes JR; Campbell KP
J Biol Chem; 1999 Sep; 274(39):27989-96. PubMed ID: 10488149
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
